| Literature DB >> 33405357 |
Maxime Lafontaine1, Anne-Sophie Lia1,2,3, Sylvie Bourthoumieu4, Hélène Beauvais-Dzugan1,2, Paco Derouault4, Marie-Christine Arné-Bes5, Catherine Sarret6, Fanny Laffargue6, Armelle Magot7, Franck Sturtz1,2, Laurent Magy2,8, Corinne Magdelaine1,2.
Abstract
We describe the clinical, electrodiagnostic, and genetic findings of three homozygous FIG4-c.122T>C patients suffering from Charcot-Marie-Tooth disease type 4J (AR-CMT-FIG4). This syndrome usually involves compound heterozygosity associating FIG4-c.122T>C, a hypomorphic allele coding an unstable FIG4-p.Ile41Thr protein, and a null allele. While the compound heterozygous patients presenting with early onset usually show rapid progression, the homozygous patients described here show the signs of relative clinical stability. As FIG4 activity is known to be dose dependent, these patients' observations could suggest that the therapeutic perspective of increasing levels of the protein to improve the phenotype of AR-CMT-FIG4-patients might be efficient.Entities:
Year: 2021 PMID: 33405357 DOI: 10.1002/acn3.51175
Source DB: PubMed Journal: Ann Clin Transl Neurol ISSN: 2328-9503 Impact factor: 4.511